JPMorgan Chase & Co’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-10
| Closed | – | – | 5238 |
|
|
2020
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 5175 |
|
|
2018
Q2 | – | Sell |
-6,100
| Closed | -$51K | – | 4924 |
|
|
2018
Q1 | $51K | Buy |
6,100
+5,334
| +696% | +$44.6K | ﹤0.01% | 4142 |
|
|
2017
Q4 | $7K | Buy |
+766
| New | +$7K | ﹤0.01% | 4531 |
|
|
2017
Q2 | – | Sell |
-4,464
| Closed | -$217K | – | 4647 |
|
|
2017
Q1 | $217K | Buy |
+4,464
| New | +$217K | ﹤0.01% | 3458 |
|
|
2016
Q2 | – | Sell |
-15,888
| Closed | -$983K | – | 4450 |
|
|
2016
Q1 | $983K | Sell |
15,888
-1,200
| -7% | -$74.2K | ﹤0.01% | 2688 |
|
|
2015
Q4 | $720K | Buy |
+17,088
| New | +$720K | ﹤0.01% | 2799 |
|
|
2014
Q4 | – | Sell |
-1,718
| Closed | -$124K | – | 3563 |
|
|
2014
Q3 | $124K | Buy |
+1,718
| New | +$124K | ﹤0.01% | 3320 |
|